Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00570843 · ClinicalTrials.gov registry record · Phase 4
Masked Comparison of a New PEG Based Artificial Tear and Optive for Comfort, Vision & Wear Time in Patients Wearing Contact Lenses
A Phase 4 study of Comfort, Vision and Wear Time, sponsored by Bp Consulting.
- Completed
- Registry status
- Phase 4
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT00570843: Completed Phase 4 study of Comfort, Vision and Wear Time, sponsored by Bp Consulting.
NCT00570843 is a Phase 4 study of Comfort, Vision and Wear Time that has completed, run by Bp Consulting. The registered enrollment target is 50 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00570843, a Phase 4 study of Comfort, Vision and Wear Time, has completed, sponsored by Bp Consulting.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of this study is to evaluate the effect of a new PEG based artificial tear as compared to Optive on comfort, wear time, and vision in patients wearing contact lenses.
Conditions Studied
Interventions
- DRUG New PEG based artificial tear
- DRUG Optive
Study Locations (1)
New York
- The New York Presbyterian Hospital-Weill Cornell Medical College - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2008-03 |
| Est. Completion | 2010-02 |
| Phase | Phase 4 |
What the finished NCT00570843 record still lists
NCT00570843 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (90% lower).
The record links to 1 condition, with Comfort, Vision and Wear Time appearing as the primary indexed condition, and to 2 interventions - of which New PEG based artificial tear is the first listed.
NCT00570843 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT00570843 about?
NCT00570843 is a clinical study titled "Masked Comparison of a New PEG Based Artificial Tear and Optive for Comfort, Vision & Wear Time in Patients Wearing Contact Lenses". The objective of this study is to evaluate the effect of a new PEG based artificial tear as compared to Optive on comfort, wear time, and vision in patients wearing contact lenses.
What is the current status of trial NCT00570843?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 50 participants. The study started on 2008-03. Estimated completion is 2010-02.
What conditions does trial NCT00570843 study?
This clinical trial studies the following conditions: Comfort, Vision and Wear Time.
What interventions are being tested in trial NCT00570843?
The interventions under investigation include: New PEG based artificial tear (DRUG), Optive (DRUG).
Who is sponsoring clinical trial NCT00570843?
This trial is sponsored by Bp Consulting, which has 10 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00570843 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00570843's enrollment target sits among peer trials
50 1255th of 2000 higher than 679 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia